Skip to main content

Peer Review reports

From: Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo

Original Submission
14 Oct 2009 Submitted Original manuscript
9 Dec 2009 Reviewed Reviewer Report - Fulvia Farabegoli
6 Jan 2010 Reviewed Reviewer Report - Matthew Burow
14 Apr 2010 Author responded Author comments - Sang-Gun Ahn
Resubmission - Version 2
14 Apr 2010 Submitted Manuscript version 2
4 May 2010 Reviewed Reviewer Report - Matthew Burow
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
10 Jun 2010 Editorially accepted
10 Jun 2010 Article published 10.1186/1471-2407-10-276

You can find further information about peer review here.

Back to article page